HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

renieramycin G

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoquinolines: 34
      - Tetrahydroisoquinolines: 44
        renieramycin G: 2

Experts

1.	Guan, Baohe: 1 article (12/2020)
2.	Liu, Zhanzhu: 1 article (12/2020)
3.	Ma, Yantao: 1 article (12/2020)
4.	Pan, Xuan: 1 article (12/2020)
5.	Zhang, Guangyan: 1 article (12/2020)
6.	Callan, Ondine: 1 article (06/2006)
7.	Estevez, Alberto: 1 article (06/2006)
8.	Lane, Jonathan W: 1 article (06/2006)
9.	Mortara, Kyle: 1 article (06/2006)
10.	Spencer, Jeffrey R: 1 article (06/2006)

Related Diseases

1.

Neoplasms (Cancer)

12/28/2020 - "(-)-Renieramycin G and (-)-homo-renieramycin G showed comparable cytotoxicity against these four cancer cell lines, which indicated that the expansion of ring C from the six-membered 1,4-piperazinone to the seven-membered 1,4-diazepanone had no obvious impact on the cytotoxicity. "
06/15/2006 - "Analogues of the tetrahydroisoquinoline family of antitumor antibiotics, 3-epi-jorumycin (3) and 3-epi-renieramycin G (4), in addition to their respective parent natural products (-)-jorumycin (1) and (-)-renieramycin G (2) were evaluated against both human colon (HCT-116) and human lung (A549) cancer cell lines. "

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	3-epi-jorumycin
3.	3-epi-renieramycin G
4.	jorumycin
5.	1,2,3,4-tetrahydroisoquinoline